Schering-Plough
Latest Schering-Plough News
-
Golden Parachutes: 21 CEOs Landed $100M PlusNardelli 2000-2007 $223,290,123 North Fork Bank John A. Kanas 1977-2006 $214,300,000 Merck & Co., Inc./ Schering - Plough Fred Hassan 2003-2009 $189,352,324 IBM Louis V. Gerstner Jr. 1993-2002 $189,005,929 Pfizer
-
Zetia Fails to Show Benefit Over Niacin for Heart Patients
simvastatin combo pill were developed by Merck / Schering - Plough , a joint development agreement giants. Early Saturday morning, Merck issued a press release confirming completion of the merger, stating, " Merck today confirms and underscores
-
Health Highlights: Oct. 5, 2009
advisory panel decided Monday. Studies by drug maker Schering - Plough showed that treatment with the drug delayed cancer recurrence increase insulin production and lower glucose production. Merck 's Januvia is also a DPP-4 inhibitor. The U.S
-
Saphris Approved for Schizophrenia and Bipolar Disorder
decreased sensitivity in and around the mouth, and weight gain, the FDA said. Saphris is produced by New Jersey-based Schering - Plough . More information The FDA has additional information about this approval.
-
Merck , Schering-Plough shareholders OK $41B deal
Shareholders of drugmakers Merck MRK and Schering - Plough SGP on Friday both overwhelmingly acquisition of smaller Schering - Plough allows Merck , the world's eighth-biggest annual sales. Merck and Schering - Plough already are partners on
-
$2.1B drug buyout: Bristol-Myers set to acquire Medarex
pharmaceutical industry has seen a rash of deals this year. The Roche Group bought the 44% of Genentech it didn't already own for $47 billion. Pfizer is buying Wyeth for $64 billion and Merck is buying Schering - Plough for $43 billion.
News
-
Top Hepatitis C Treatments Equally Effective
will allow patients to avoid side effects and the expense of taking unnecessary drugs. The study was funded by the Schering - Plough Corp., the maker and provider of the study drugs ribavirin and peginterferon alfa-b. More information The U
-
Despite recession, companies are beating profit expectations
favorable tax settlements. Merck stuck with its full-year billion to $23.7 billion. At Schering - Plough sgp , profit jumped 49% in the one-time costs. In March, Merck agreed to buy Schering - Plough for $41.1 billion. The
-
Drugmaker Merck posts 12% profit drop, beats forecasts
related to its acquisition of Schering - Plough that totaled 9 cents a share to favorable tax settlements. Merck stuck with its full-year 2009 billion to $23.7 billion. At Schering - Plough sgp , profit jumped 49% in the second
-
J&J takes on Alzheimer's disease with $1B stake in Elan
missed is the fact that J&J has a change-and-control battle going with Schering - Plough " over shared sales of arthritis drugs because Schering is being acquired by Merck for $41.1 billion, said analyst Steve Brozak of WBB Securities
-
New Drug Promising Against Rheumatoid Arthritis
abatacept, golimumab might be a good option." The study, which was funded by drug makers Centocor, Inc. and Schering - Plough , appears online June 29 in The Lancet . Rheumatoid arthritis is a chronic inflammatory disease that affects about
-
For Diabetics, Heart Drugs Are Just as Effective as Bypass Surgery or Stents
Medical Imaging, Astellas Pharma, Merck , Abbott Laboratories, Pfizer interest with sanofi-aventis, Schering - Plough , Axio, Eli Lilly, CV Therapeutics, Takeda, Merck , Blue Cross Blue Shield Technology
-
CT Lung Cancer Screening Leaves a Trail of False Positives
Abraxis, Biogen-Idec, and Johnson and Johnson. Edelman has reported financial links with Bristol-Myers Squibb, Cyclacel, Eli Lilly, Genentech, Tragara Pharmaceuticals, Endocyte, Geron, Human Genome Sciences and Schering - Plough .
Videos
-
Webcast: Stem Cell Ban Lifted, Say Hi Album Review, Barbie Turns 50leaders need to support president Obama's efforts to repair the economy. Pharmaceutical giant Merck announced today it's buying competitor Schering - Plough . For 41 billion dollars in cash and stock. The combined companies will become the nation's
need to support president Obama's efforts to repair the economy. Pharmaceutical giant Merck announced today it's buying competitor Schering-Plough . For 41 billion dollars in cash and stock. The combined companies will become the nation's second largest. Drugmaker in the industry facing -
Markets Are Looking Upgood bats for the company. Different drugmaker Merck else report this morning how to they can't way to gross sales now. Back in November they Schering rather bought Schering - Plough that acquisition closed but even mark saying
a way to gross sales now. Back in November -- they -- Schering -- rather bought Schering-Plough that acquisition closed but even mark saying. But we have a 100000 employees probably -- -- you about a 15% cuts. By
